跳至主要内容
临床试验/JPRN-UMIN000037558
JPRN-UMIN000037558已完成未知

Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA. A randomized, double-blind, crossover study. - Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA.

FANCL Corporation0 个研究点目标入组 60 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. Patient with dyslipidaemia 2. Medical treatment for some diseases 3. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases 4. Sublects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 5. Can't stop to take a supplement during the study period. 6. Difficulty in collecting blood. 7. Smoker 8. Subjects who are planned to participate in other clinical study. 9. Subjects who are judged as unsuitable for the study by the investigator for other reason.

研究者

相似试验